Fig. 1From: Effects of a clinical pathway on antibiotic use in patients with community-acquired pneumonia: a multi-site study in ChinaDistribution of antibiotic use in the CP and non-CP groupsaRecommended antibiotics include respiratory quinolones, β-lactam/β-lactamase inhibitors, 2nd-generation cephalosporins, macrolides and the recommended 3rd-generation cephalosporins (ceftriaxone and cefotaxime). *p < 0.05, ***p < 0.001.Back to article page